Céline Vidaillac

1.6k total citations
43 papers, 1.2k citations indexed

About

Céline Vidaillac is a scholar working on Infectious Diseases, Pharmacology and Molecular Biology. According to data from OpenAlex, Céline Vidaillac has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 18 papers in Pharmacology and 15 papers in Molecular Biology. Recurrent topics in Céline Vidaillac's work include Antimicrobial Resistance in Staphylococcus (23 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Antibiotic Resistance in Bacteria (9 papers). Céline Vidaillac is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (23 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Antibiotic Resistance in Bacteria (9 papers). Céline Vidaillac collaborates with scholars based in United States, Singapore and France. Céline Vidaillac's co-authors include Michael J. Rybak, Jorge Parra-Ruiz, Molly E. Steed, Raphaël E. Duval, Warren E. Rose, Sanjay H. Chotirmall, Steve N. Leonard, Hélio S. Sader, Ronald N. Jones and Claudine Quentin and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Céline Vidaillac

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Céline Vidaillac United States	20	601	382	357	354	263	43	1.2k
Lois M. Ednie United States	24	717 1.2×	243 0.6×	494 1.4×	456 1.3×	324 1.2×	49	1.3k
A. Simon Lynch United States	19	366 0.6×	605 1.6×	300 0.8×	518 1.5×	82 0.3×	29	1.4k
Bianca Graves Australia	8	373 0.6×	231 0.6×	352 1.0×	421 1.2×	220 0.8×	12	1.2k
Gengrong Lin United States	19	450 0.7×	188 0.5×	537 1.5×	437 1.2×	172 0.7×	36	1.2k
Klaudia Kosowska-Shick United States	19	708 1.2×	380 1.0×	325 0.9×	320 0.9×	262 1.0×	35	1.1k
Michael Kresken Germany	21	448 0.7×	272 0.7×	426 1.2×	669 1.9×	310 1.2×	73	1.4k
Fabrice Compain France	18	309 0.5×	229 0.6×	190 0.5×	650 1.8×	100 0.4×	42	1.2k
Angela M. Nilius United States	23	542 0.9×	428 1.1×	357 1.0×	269 0.8×	95 0.4×	57	1.5k
Björn A. Espedido Australia	13	702 1.2×	331 0.9×	111 0.3×	314 0.9×	469 1.8×	19	1.2k
Silke Besier Germany	16	502 0.8×	436 1.1×	100 0.3×	304 0.9×	148 0.6×	28	985

Countries citing papers authored by Céline Vidaillac

Since Specialization

Citations

This map shows the geographic impact of Céline Vidaillac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Vidaillac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Vidaillac more than expected).

Fields of papers citing papers by Céline Vidaillac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Vidaillac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Vidaillac. The network helps show where Céline Vidaillac may publish in the future.

Co-authorship network of co-authors of Céline Vidaillac

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Vidaillac. A scholar is included among the top collaborators of Céline Vidaillac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Vidaillac. Céline Vidaillac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nguyen, Quyen T.K., et al.. (2020). Towards a fair and transparent research participant compensation and reimbursement framework in Vietnam. International Health. 12(6). 533–540. 3 indexed citations

Tran, The-Thien, Hong Yu, Céline Vidaillac, et al.. (2019). An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis. International Journal of Pharmaceutics. 559. 382–392. 15 indexed citations

Tran, The-Thien, Céline Vidaillac, Hong Yu, et al.. (2018). A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart. International Journal of Pharmaceutics. 547(1-2). 368–376. 16 indexed citations

Vidaillac, Céline, et al.. (2018). Gender differences in bronchiectasis: a real issue?. Breathe. 14(2). 108–121. 51 indexed citations

Tran, The-Thien, Céline Vidaillac, R Chandrasekaran, et al.. (2017). Inhalable Ciprofloxacin-Nanoplex (CIP-Np) combined with mannitol as a novel bronchiectasis therapeutic. PA4120–PA4120. 1 indexed citations

Vidaillac, Céline, et al.. (2014). Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm. Infectious Diseases and Therapy. 4(1). 51–65. 40 indexed citations

Vidaillac, Céline, Susana Gardete, Ryan Tewhey, et al.. (2013). Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus. The Journal of Infectious Diseases. 208(1). 67–74. 34 indexed citations

Dewal, Mahender B., Amit S. Wani, Céline Vidaillac, et al.. (2012). Thieno[2,3-d]pyrimidinedione derivatives as antibacterial agents. European Journal of Medicinal Chemistry. 51. 145–153. 45 indexed citations

Hayakawa, Kayoko, Dror Marchaim, Céline Vidaillac, et al.. (2011). Growing Prevalence of Vancomycin-Resistant Enterococcus faecalis in the Region with the Highest Prevalence of Vancomycin-Resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology. 32(9). 922–924. 16 indexed citations

10.

Vidaillac, Céline, Jorge Parra-Ruiz, & Michael J. Rybak. (2011). In vitro time–kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin. Diagnostic Microbiology and Infectious Disease. 71(4). 470–473. 21 indexed citations

11.

Patel, Diixa, Céline Vidaillac, Molly E. Steed, et al.. (2011). Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus. International Journal of Antimicrobial Agents. 38(5). 442–446. 36 indexed citations

12.

Vidaillac, Céline, Molly E. Steed, & Michael J. Rybak. (2011). Impact of Dose De-Escalation and Escalation on Daptomycin's Pharmacodynamics against Clinical Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Model. Antimicrobial Agents and Chemotherapy. 55(5). 2160–2165. 8 indexed citations

13.

Vidaillac, Céline, et al.. (2011). In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates. International Journal of Antimicrobial Agents. 38(4). 301–306. 8 indexed citations

14.

Steed, Molly E., Céline Vidaillac, & Michael J. Rybak. (2010). Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations. Antimicrobial Agents and Chemotherapy. 54(12). 5187–5192. 47 indexed citations

15.

Vidaillac, Céline, Jeffrey R. Aeschlimann, & Michael J. Rybak. (2010). A new assay to determine Oritavancin concentrations. The Journal of Antibiotics. 63(12). 717–719. 1 indexed citations

16.

Vidaillac, Céline, Steve N. Leonard, & Michael J. Rybak. (2010). In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. International Journal of Antimicrobial Agents. 35(6). 527–530. 19 indexed citations

17.

Vidaillac, Céline & Michael J. Rybak. (2009). Ceftobiprole: First Cephalosporin with Activity Against Methicillin‐Resistant Staphylococcus aureus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(5). 511–525. 18 indexed citations

18.

Vidaillac, Céline. (2008). In Vitro Activity and Aminoglycoside Synergy of Ceftaroline (CPT) Against Clinical Isolates of Hospital-Acquired (HA) Methicillin-Resistant Staphylococcus aureus (MRSA). 46th Annual Meeting. 1 indexed citations

19.

Vidaillac, Céline, Jean Guillon, Stéphane Moreau, et al.. (2007). Synthesis of new 4-[2-(alkylamino)ethylthio]pyrrolo[1,2- a ]quinoxaline and 5-[2-(alkylamino)ethylthio]pyrrolo[1,2- a ]thieno[3,2- e ]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(5). 620–631. 15 indexed citations

20.

Arpin, Corinne, et al.. (2006). Activity of Gatifloxacin in an In Vitro Pharmacokinetic-Pharmacodynamic Model against Staphylococcus aureus Strains either Susceptible to Ciprofloxacin or Exhibiting Various Levels and Mechanisms of Ciprofloxacin Resistance. Antimicrobial Agents and Chemotherapy. 50(6). 1931–1936. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact